KLAR — Klaria Pharma Holding AB (publ) Balance Sheet
0.000.00%
- SEK166.47m
- SEK165.88m
- SEK2.25m
Annual balance sheet for Klaria Pharma Holding AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 31.3 | 25.5 | 16.8 | 1.25 | 0.598 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.38 | 1.76 | 23.5 | 1.26 | 2.25 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 33 | 27.8 | 40.8 | 72.9 | 2.85 |
Net Property, Plant And Equipment | 0.281 | 1.72 | 1.07 | 0.027 | 1.47 |
Net Intangible Assets | |||||
Total Assets | 132 | 118 | 120 | 72.9 | 57.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22.8 | 47.9 | 43.8 | 31.8 | 53.3 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 22.8 | 48.9 | 44.2 | 31.8 | 54 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 110 | 69.4 | 76.1 | 41.1 | 3.31 |
Total Liabilities & Shareholders' Equity | 132 | 118 | 120 | 72.9 | 57.3 |
Total Common Shares Outstanding |